Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression

Archives of Ophthalmology

Volumn 127, Issue 9, 2009, Pages 1129-1134

  De Moraes, Carlos Gustavo V ^a   Prata, Tiago S ^a   Tello, Celso ^a,b   Ritch, Robert ^a,b   Liebmann, Jeffrey M ^a,c,d,e  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EAR AND THROAT HOSPITAL   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; FEMALE; GLAUCOMA; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; VISUAL FIELD DEFECT;

AGED; ALGORITHMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PERIMETRY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 70349244739     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.165     Document Type: Article

References (30)

1. Medeiros FA, Weinreb RN. Predictive models to estimate the risk of glaucoma development and progression. Prog Brain Res. 2008;173:15-24.
2. Parrish RK II, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447-1455. (Pubitemid 28055876)
3. Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002;43(4):1059-1067. (Pubitemid 34258274)
4. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145(2):343-353.
5. Heijl A, Bengtsson B, Chauhan BC, et al. A comparison of visual field progression criteria of 3 major glaucoma trials in Early Manifest Glaucoma Trial patients. Ophthalmology. 2008;115(9):1557-1565.
6. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114(11):1965-1972. (Pubitemid 350016362)
7. Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I; EGPS Group. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol. 2007;144(2):266-275. (Pubitemid 47094739)
8. Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK; CIGTS Study Investigators. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors. Ophthalmology. 2009;116(2):200-207.
9. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 12: baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134(4):499-512.
10. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003;136(5):805-813. (Pubitemid 37330022)
11. Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. St Louis, MO: Mosby Inc; 1999.
12. Viswanathan AC, Fitzke FW, Hitchings RA. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997;81(12):1037-1042. (Pubitemid 27526819)
13. Crabb DP, Fitzke FW, McNaught AI, Edgar DF, Hitchings RA. Improving the prediction of visual field progression in glaucoma using spatial processing. Ophthalmology. 1997;104(3):517-524.
14. Strouthidis NG, Scott A, Peter NM, Garway-Heath DF. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci. 2006;47(7):2904-2910. (Pubitemid 351639765)
15. Viswanathan AC, Crabb DP, McNaught AI, et al. Interobserver agreement on visual field progression in glaucoma: a comparison of methods. Br J Ophthalmol. 2003;87(6):726-730. (Pubitemid 36649225)
16. Chauhan BC, Garway-Heath DF, Goñi FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92(4):569-573.
17. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48-56.
18. Mikelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma. Am J Ophthalmol. 1984;98(4):443-445. (Pubitemid 14021806)
19. Boden C, Blumenthal EZ, Pascual J, et al. Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol. 2004;138(6):1029-1036. (Pubitemid 40040020)
20. Boden C, Sample PA, Boehm AG, Vasile C, Akinepalli R, Weinreb RN. The structure-function relationship in eyes with glaucomatous visual field loss that crosses the horizontal meridian. Arch Ophthalmol. 2002;120(7):907-912. (Pubitemid 34755543)
21. Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma, 1: light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci. 1978;17(9):838-846. (Pubitemid 8389865)
22. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci. 1977;16(5):426-441.
23. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: the site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99(4):635-649.
24. Burgoyne CF, Downs JC. Premise and prediction: how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J Glaucoma. 2008;17(4):318-328.
25. Jonas JB, Fernández MC, Stürmer J. Pattern of glaucomatous neuroretinal rim loss. Ophthalmology. 1993;100(1):63-68. (Pubitemid 23041132)
26. Jonas JB, Mardin CY, Schlötzer-Schrehardt U, Naumann GO. Morphometry of the human lamina cribrosa surface. Invest Ophthalmol Vis Sci. 1991;32(2):401-405.
27. Demirel S, Fortune B, Fan J, et al. Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data. Invest Ophthalmol Vis Sci. 2009;50(2):674-680.
28. Pascual JP, Schiefer U, Paetzold J, et al. Spatial characteristics of visual field progression determined by Monte Carlo simulation: diagnostic innovations in glaucoma study. Invest Ophthalmol Vis Sci. 2007;48(4):1642-1650. (Pubitemid 351261349)
29. Nouri-Mahdavi K, Hoffman D, Gaasterland D, Caprioli J. Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci. 2004;45(12):4346-4351. (Pubitemid 39564659)
30. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44(9):3873-3879. (Pubitemid 37047957)